Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 28Myeloid 9Dermatologic 8Plasma cell 3Genitourinary 3Thoracic 2Lymphoid 2Gynecologic 2Classical hematology 2CNS 2Tumor-Agnostic 1Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Precancerous Conditions 1

Interventions

Biopsy 8Polymerase Chain Reaction 6Peripheral Blood Stem Cell Transplantation 5Epoetin Alfa 5Surveys and Questionnaires 4Sulindac 4Microarray Analysis 4Gene Expression Profiling 4Early Intervention, Educational 4Cyclophosphamide 4Colposcopy 4Cisplatin 4Cetuximab 4Celecoxib 4fludarabine phosphate 3Vaginal Smears 3Selenium 3Pemetrexed 3Methotrexate 3Imiquimod 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Eflornithine 3Darbepoetin alfa 3Aspirin 3Antilymphocyte Serum 3Whole-Body Irradiation 2Vitamin E 2Videotape Recording 2Tacrolimus 2Radiotherapy, Intensity-Modulated 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tretinoin × Other neoplasm × Clear all
NCT00003598 2010-09-22

IRB 1996-0189

University of Michigan Rogel Cancer Center

Phase NA Completed
180 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡